Biosimilar Ziextenzo® (pegfilgrastim), a long-acting version of supportive oncology medicine filgrastim, is now approved for use in all reference medicine […]
Press Release First 5G New Radio end-to-end pilot in Singapore on 3.5GHz frequency band compliant with 3GPP standards Demonstrated high-performance, […]